Bookmark and Share

News Article

How will German health reform impact pharma market access in 2012?
German watchdog IQWiG is already busy in 2012 having published five early benefit assessments since the new year with three more slated for February. What remains sure is that the assessment body remains stringent and sticks to its principles. (Source:  IHS Healthcare and Pharma Blog, 2/2/2012)

Read more.
Bookmark and Share